Scott Thomas Jackson - Net Worth and Insider Trading
Scott Thomas Jackson Net Worth
The estimated net worth of Scott Thomas Jackson is at least $2 Million dollars as of 2024-06-04. Scott Thomas Jackson is the CEO of Celator Pharmaceuticals Inc and owns about 50,043 shares of Celator Pharmaceuticals Inc (CPXX) stock worth over $2 Million. Details can be seen in Scott Thomas Jackson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott Thomas Jackson has not made any transactions after 2015-10-06 and currently still holds the listed stock(s).
Transaction Summary of Scott Thomas Jackson
Scott Thomas Jackson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott Thomas Jackson owns 4 companies in total, including Spero Therapeutics Inc (SPRO) , GlycoMimetics Inc (GLYC) , and Macrogenics Inc (MGNX) among others .
Click here to see the complete history of Scott Thomas Jackson’s form 4 insider trades.
Insider Ownership Summary of Scott Thomas Jackson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SPRO | Spero Therapeutics Inc | 2020-04-16 | director |
| GLYC | GlycoMimetics Inc | 2018-11-27 | director |
| MGNX | Macrogenics Inc | 2017-01-24 | director |
 | | 2016-07-12 | director & Chief Executive Officer |
Scott Thomas Jackson Latest Holdings Summary
Scott Thomas Jackson currently owns a total of 1 stock. Scott Thomas Jackson owns 50,043 shares of Celator Pharmaceuticals Inc (CPXX) as of October 6, 2015, with a value of $2 Million.
Latest Holdings of Scott Thomas Jackson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPXX | Celator Pharmaceuticals Inc | 2015-10-06 | 50,043 | 30.24 | 1,513,300 |
Holding Weightings of Scott Thomas Jackson
Scott Thomas Jackson Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott Thomas Jackson has made a total of 0 transactions in Celator Pharmaceuticals Inc (CPXX) over the past 5 years. The most-recent trade in Celator Pharmaceuticals Inc is the acquisition of 14,450 shares on October 6, 2015, which cost Scott Thomas Jackson around $25,143.
Insider Trading History of Scott Thomas Jackson
- 1
Scott Thomas Jackson Trading Performance
GuruFocus tracks the stock performance after each of Scott Thomas Jackson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott Thomas Jackson is 3.39%. GuruFocus also compares Scott Thomas Jackson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott Thomas Jackson within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Scott Thomas Jackson's insider trading performs compared to the benchmark.
Performance of Scott Thomas Jackson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.13 | | | | | |
| Relative Return to S&P 500(%) | -4.89 | | | | | |
Scott Thomas Jackson Ownership Network
Scott Thomas Jackson Owned Company Details
What does Spero Therapeutics Inc do?
Who are the key executives at Spero Therapeutics Inc?
Scott Thomas Jackson is the director of Spero Therapeutics Inc. Other key executives at Spero Therapeutics Inc include Chief Financial Officer Sath Shukla , Chief Medical Officer Kamal Hamed , and Chief Development Officer Timothy Keutzer .
Spero Therapeutics Inc (SPRO) Insider Trades Summary
Over the past 18 months, Scott Thomas Jackson made no insider transaction in Spero Therapeutics Inc (SPRO). Other recent insider transactions involving Spero Therapeutics Inc (SPRO) include a net sale of 91,515 shares made by Sath Shukla , a net sale of 85,121 shares made by Ankit Mahadevia , and a net sale of 36,219 shares made by Timothy Keutzer .
In summary, during the past 3 months, insiders sold 0 shares of Spero Therapeutics Inc (SPRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 316,580 shares of Spero Therapeutics Inc (SPRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 316,580 shares.
Spero Therapeutics Inc (SPRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spero Therapeutics Inc Insider Transactions
Scott Thomas Jackson Mailing Address
Above is the net worth, insider trading, and ownership report for Scott Thomas Jackson. You might contact Scott Thomas Jackson via mailing address: 303b College Road East, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
